Specialty Drug Distribution Market

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers? ability to track utilization.

Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.

Specialty Drug Distribution Market contains market size and forecasts of Specialty Drug Distribution in Global, including the following market information:

Global Specialty Drug Distribution Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Specialty Drug Distribution market was valued at 275360 million in 2021 and is projected to reach US$ 541540 million by 2028, at a CAGR of 10.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Specialty Drug Distribution include AmerisourceBergen, Mckesson, Cardinal Health, Phoenix, Medipal Holdings, Alliance Healthcare, Sinopharm, Express Scripts and Shanghai Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Specialty Drug Distribution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Specialty Drug Distribution Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Specialty Drug Distribution Market Segment Percentages, by Type, 2021 (%)

Oncology

Rheumatoid Arthritis

Multiple Sclerosis

Hemophilia

Others

Global Specialty Drug Distribution Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Specialty Drug Distribution Market Segment Percentages, by Application, 2021 (%)

Hospital and Clinic

Pharmacy

Others

Global Specialty Drug Distribution Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Specialty Drug Distribution Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Specialty Drug Distribution revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Specialty Drug Distribution revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AmerisourceBergen

Mckesson

Cardinal Health

Phoenix

Medipal Holdings

Alliance Healthcare

Sinopharm

Express Scripts

Shanghai Pharma

Anda

Jointown

Max Pharma